Protalix completes follow-on

Protalix Biotherapeutics Inc. (NYSE-A:PLX; Tel Aviv:PLX), Carmiel, Israel Business: Endocrine/Metabolic, Biosimilars, Biomanufacturing Date completed: 2/16/12 Type: Follow-on Raised: $23.6 million Sha...